EORTC Early Clinical Studies Group (ECSG)

Author PubWeight™ 0.81^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme.	Eur J Cancer	2002	0.85